Probing the dynamic structure-function and structure-free energy relationships of the corona virus main protease with Biodynamics theory
Probing the dynamic structure-function and structure-free energy relationships of the corona virus main protease with Biodynamics theory
AbstractThe SARS-CoV-2 Main protease (Mpro) is of major interest as an anti-viral drug target. Structure-based virtual screening efforts, fueled by a growing list of apo and inhibitor-bound SARS-CoV/CoV-2 Mprocrystal structures, are underway in many labs. However, little is known about the dynamic enzyme mechanism, which is needed to inform both structure-based design and assay development. Here, we apply Biodynamics theory to characterize the structural dynamics of substrate-induced Mproactivation, and explore the implications thereof for efficacious inhibition under non-equilibrium conditions. The catalytic cycle (including tetrahedral intermediate formation and hydrolysis) is governed byconcerteddynamic structural rearrangements of domain 3 and the m-shaped loop (residues 132-147) on which Cys145 (comprising the thiolate nucleophile and one-half of the oxyanion hole) and Gly143 reside (comprising the other half of the oxyanion hole). In particular:Domain 3 undergoes dynamic rigid-body rotations about the domain 2-3 linker, alternately visiting two conformational states (denoted as).The Gly143-containing crest of the m-shaped loop (denoted as crest B) undergoes up and down translations in concert with the domain 3 rotations (denoted as, whereas the Cys145-containing crest (denoted as crest A) remains statically in the up position. The crest B translations are driven by conformational transitions within the rising leg of the loop (Lys137-Asn142).We propose that substrates associate to thestate, which promotes thestate, dimerization (denoted as-substrate), and catalysis. The structure resets to the dynamic monomeric form upon dissociation of the N-terminal product. We describe the energetics of the aforementioned state transitions, and address the implications of our proposed mechanism for efficacious Mproinhibition under native-like conditions.
- Novartis (United Kingdom) United Kingdom
- Novartis (United States) United States
- Novartis (Switzerland) Switzerland
Pharmacology, Pharmacology (medical)
Pharmacology, Pharmacology (medical)
11 Research products, page 1 of 2
- 2013IsRelatedTo
- 2013IsAmongTopNSimilarDocuments
- 1984IsRelatedTo
- 2013IsRelatedTo
- 2020IsRelatedTo
- 2020IsRelatedTo
- 2007IsRelatedTo
- 2005IsRelatedTo
- 2020IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).15 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
